Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Financial News

Omega seeking broad swath of deal types for $438M sixth fund

Why Omega Funds is keeping a balanced approach with its latest and largest fund

December 11, 2019 1:17 PM UTC
Updated on Dec 12, 2019 at 1:15 AM UTC

For its sixth and largest investment vehicle, Omega Funds intends to deploy a variety of investment tools in deals spanning early and late stage companies, with an emphasis on proven management teams.

As Omega invests its $438 million Fund VI, Managing Director Otello Stampacchia told BioCentury the firm will create a handful of start-ups from scratch, participate in syndicated rounds for early and later-stage private companies as well as publicly traded ones, and execute direct secondary investments...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Omega Funds